Trial Profile
An Healthy Volunteer, Open-Label, Cross-Over Phase I Study to Determine the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose of AWP-09VDB-S under Fed and Fasted Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Ala Wai Pharma
- 18 May 2017 Study has been changed from recruiting to completed.
- 24 Nov 2016 New trial record